Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
Cross-reactivity00:42

Cross-reactivity

Overview
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comprehensive overview of paracetamol poisoning admissions and long-term outcomes in New South Wales, Australia: a retrospective linked data cohort (PAVLOVA-3).

The Lancet regional health. Western Pacific·2026
Same author

A prospective series of acute rivaroxaban overdose, coagulopathy and bleeding complications (ATOM 11).

British journal of clinical pharmacology·2026
Same author

Poisoning in the elderly is increasing rapidly and is more severe than younger patients.

Clinical toxicology (Philadelphia, Pa.)·2026
Same author

Understanding Consumer Attitudes and Awareness After Admission to a Toxicology Unit.

Emergency medicine Australasia : EMA·2026
Same author

An accurate and reproducible method to measure snake venom anticoagulant activity.

Journal of pharmacological and toxicological methods·2026
Same author

Neuromuscular and cytotoxic effects of common cobra (<i>Naja naja</i>) bites in rural Sri Lanka.

Clinical toxicology (Philadelphia, Pa.)·2025

Related Experiment Video

Updated: Jun 20, 2026

Captive Maintenance and Venom Extraction of Tityus serrulatus (Brazilian Yellow Scorpion) for Antivenom Production
05:27

Captive Maintenance and Venom Extraction of Tityus serrulatus (Brazilian Yellow Scorpion) for Antivenom Production

Published on: October 6, 2023

Antivenom efficacy or effectiveness: the Australian experience.

Geoffrey K Isbister1

  • 1Department of Clinical Toxicology and Pharmacology, Calvary Mater Newcastle, Newcastle, New South Wales, Australia. geoffrey.isbister@menzies.edu.au

Toxicology
|September 29, 2009
PubMed
Summary

Antivenom effectiveness in treating venomous bites is debated, with clinical outcomes sometimes differing from laboratory results. Further research is crucial to understand antivenom efficacy and improve patient treatment.

More Related Videos

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

Related Experiment Videos

Last Updated: Jun 20, 2026

Captive Maintenance and Venom Extraction of Tityus serrulatus (Brazilian Yellow Scorpion) for Antivenom Production
05:27

Captive Maintenance and Venom Extraction of Tityus serrulatus (Brazilian Yellow Scorpion) for Antivenom Production

Published on: October 6, 2023

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

Area of Science:

  • Toxicology
  • Clinical Pharmacology
  • Immunology

Background:

  • Antivenoms are widely used but their clinical effectiveness is not fully established.
  • Efficacy (in vitro neutralization) and effectiveness (clinical reversal) of antivenoms are distinct concepts.
  • Concerns exist regarding antivenom quality and efficacy, alongside potential reasons for treatment failure.

Purpose of the Study:

  • To critically evaluate the clinical effectiveness of antivenoms, distinguishing it from in vitro efficacy.
  • To explore reasons for antivenom failure in human envenoming cases.
  • To guide future research into optimizing antivenom therapy.

Main Methods:

  • Review of existing literature on antivenom use and effectiveness.
  • Analysis of clinical case studies and observational data.
  • Comparison of in vitro antivenom efficacy with clinical outcomes.

Main Results:

  • Antivenom effectiveness in clinical settings is questioned by recent Australian studies for specific envenomings (e.g., snakebite coagulopathy, spider, and jellyfish antivenoms).
  • Brown snake antivenom's in vitro efficacy against coagulopathy does not always translate to altered clinical timelines.
  • Reasons for antivenom failure extend beyond inefficacy, including irreversibility of effects and pharmacokinetic challenges.

Conclusions:

  • Apparent antivenom ineffectiveness should prompt further investigation, not dismissal of antivenom utility.
  • Research should focus on envenoming pathophysiology, venom and antivenom pharmacokinetics, and factors influencing treatment success.
  • Optimizing antivenom effectiveness requires understanding specific venom types, clinical presentations, and administration timing.